Results 31 to 40 of about 12,890,416 (254)
Immune-related hematological adverse events are amongst the rare but potentially life-threatening complications of immune checkpoint inhibitors.
Roser Calvo
doaj +1 more source
Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Christopher J Cates +3 more
core +1 more source
Details of immune-related adverse events.
Details of immune-related adverse events.
Yuji Miyoshi (3172629) +5 more
core +1 more source
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]
An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Christopher J Cates +3 more
core +1 more source
Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review
Immune checkpoint inhibitors have been increasingly used to treat various malignant neoplasms. Despite their superior efficacy in treating certain ones, their global immune-activation effect leads to systemic side effects, referred to as immune-related ...
Elizabeth A. Montgomery +3 more
core +1 more source
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer [PDF]
Editorial on the Research Topic Immune-Related Adverse Events for Patients with Lung ...
Frey, Benjamin +6 more
core +1 more source
Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review
Immune checkpoint inhibitors have been increasingly used to treat various malignant neoplasms. Despite their superior efficacy in treating certain ones, their global immune-activation effect leads to systemic side effects, referred to as immune-related ...
Alruwaii, Zainab I. +3 more
core +1 more source
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-related adverse events (irAEs) is an obstacle ...
Xiao-Hui Jia +9 more
doaj +1 more source
Immunotherapy for malignant tumors is a hot spot in current research and the treatment of cancer. The activation of programmed cell death receptor‐1 (PD‐1) and cytotoxic T lymphocyte‐associated antigen 4 (CTLA)‐4 relevant signaling pathway can inhibit ...
Yue Li +10 more
doaj +1 more source
BackgroundImmune checkpoint inhibitors (ICIs) are associated with different immune-related adverse events (irAEs), but there is limited evidence regarding the association between urinary incontinence and ICIs.MethodsWe described the case of a patient ...
Yizhang Hu +4 more
doaj +1 more source

